← All diseases
Cancer
Acute myeloid leukemia
Would you like to receive a message when there is new research on Acute myeloid leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you will be notified as soon as new research on Acute myeloid leukemia is available. View what Premium costs.
Publications and studies (2129)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Update on the Diagnosis and Stratification of Patients with Acute Myeloid Leukemia: An Urgent National Need]. (2023/05/01) ♡
- Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis. (2023/04/28) ♡
- Anti-Steatotic Effects of Chlorella vulgaris, Nannochloropsis gaditana and Gracilaria vermiculophylla Algae Extracts in AML-12 Hepatocytes. (2023/04/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. (2023/04/14) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. (2023/04/06) ♡
- Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional 'radar' flow cytometric plot analysis method. (2023/04/01) ♡
- Multiple Organ Dysfunction and Critically Ill Children With Acute Myeloid Leukemia: Single-Center Retrospective Cohort Study. (2023/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Systematic Review of Antimicrobial Lock Solutions for Prevention of Bacteremia in Pediatric Patients With Intestinal Failure. (2023/04/01) ♡
- Higher mTOR Expression: A Marker of Poor Outcome in Patients with de Novo AML. (2023/04/01) ♡
- Exposure-Response Relationship of Posaconazole Suspension in the Prophylaxis of Invasive Fungal Infections in Patients with Acute Myeloid Leukemia. (2023/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Erythrophagocytosis by leukemic blasts with Auer body in acute myeloid leukemia with double mutant CEBPA. (2023/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat model. (2023/04/01) ♡
- Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice. (2023/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Venetoclax in acute myeloid leukemia. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process. (2023/03/17) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Study on the hepatotoxicity and potential mechanism of gefitinib based on CYP450 in mice and AML12 cells. (2023/03/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia. (2023/03/01) ♡
- A Novel Likely Pathogenic Variant in the RUNX1 Gene as the Cause of Congenital Thrombocytopenia. (2023/03/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects. (2023/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 42-Year-Old Man with a Seizure. (2023/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Corrigendum: Murine models of acute myeloid leukemia. (2023/02/23) ♡
- Nutritional and prognostic value of bioelectrical phase angle as a potentially modifiable marker in acute myeloid leukemia. (2023/02/13) ♡
- Different recovery patterns of CMV-specific and WT1-specific T cells in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: Impact of CMV infection and leukemia relapse. (2023/02/07) ♡
- Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. (2023/02/06) ♡
- High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia. (2023/02/01) ♡
- Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia. (2023/02/01) ♡
- Survival in Elderly Patients Diagnosed With Acute Myeloid Leukemia: A Hospital-Based Study. (2023/02/01) ♡
- In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia. (2023/02/01) ♡
- Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemia. (2023/02/01) ♡
- The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure. (2023/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort. (2023/02/01) ♡
- Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway. (2023/01/30) ♡
- Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses. (2023/01/26) ♡
- Four Different Structural Dietary Polyphenols, Especially Dihydromyricetin, Possess Superior Protective Effect on Ethanol-Induced ICE-6 and AML-12 Cytotoxicity: The Role of CYP2E1 and Keap1-Nrf2 Pathways. (2023/01/25) ♡
- Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia. (2023/01/24) ♡
- High-dose cytarabine monotherapy is superior to standard-dose cytarabine-based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification. (2023/01/16) ♡
- Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia. (2023/01/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature. (2023/01/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data. (2023/01/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Identification of acute promyelocytic leukemia during osimertinib resistance followed by granulocyte colony-stimulating factor and pembrolizumab. (2023/01/13) ♡
- Identification of autophagy-associated genes and prognostic implications in adults with acute myeloid leukemia by integrated bioinformatics analysis. (2023/01/13) ♡
- Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections. (2023/01/11) ♡
- Leukemia-associated truncation of granulocyte colony-stimulating factor receptor impacts granulopoiesis throughout the life-course. (2023/01/10) ♡
- Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia. (2023/01/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement. (2023/01/09) ♡
- The trace that is valuable: serum copper and copper to zinc ratio for survival prediction in younger patients with newly diagnosed acute myeloid leukaemia. (2023/01/05) ♡
- Decrease in Mortality from Sepsis: Impact of the Multidisciplinary Program for the Hematologic Patient at Very High Risk. (2023/01/01) ♡
- The Effect of Telomerase Inhibition on NK Cell Activity in Acute Myeloid Leukemia. (2023/01/01) ♡
- Twist1 Promoter Methylation Regulates the Proliferation and Apoptosis of Acute Myeloid Leukemia Cells via PI3K/AKT Pathway. (2023/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.